Speakers

Aaron Hambrick

Associate Scientific Director, Medical Payer Strategy - Psychiatry & Neuroscience

Abbvie

Adam Phipps

Associate VP, Government Payer Strategy, Alzheimer's (US)

Eli Lilly & Co.

Ali Benakila

Global Pharma Diagnostic Strategy Leader

Roche

Andreas Jeromin

Chief Scientific Officer

New Diagnostic Company emerging from Stealth Mode

Brenda Hendron

Vice President of Payer Solutions

LabCorp

Chuck Collins

Independent Consultant

The HSS Group

Dr. Elicia DeParolesa, PharmD

Sr. Manager: Clinical Product Design, Strategy and Innovation

CVS Health

Ginger Johnson

President

Lumanity

Julio Rojas

Associate Professor of Neurology

UCSF

Kevin Lanzo

Principal Consultant

Pharmaka Clinical Consulting

Kristophe Diaz

Chief Scientific Officer, Executive Director & Vice President, Scientific Affairs

Cure PSP

Shaheen Lakhan

Chief Medical Officer

Click Therapeutics

Shawn Carlson

VP Head of US Market Access

Roche

Steve Beller

Chief Commercial Officer

Neurolief